Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and rucaparib

gemcitabine has been researched along with rucaparib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Azzariti, A; Carioggia, E; Leo, MG; Lioce, M; Mantuano, P; Paradiso, A; Porcelli, L; Quatrale, AE; Rolland, JF; Silvestris, N1
Bhattacharjee, V; Yen, TJ; Zhou, Y1

Other Studies

4 other study(ies) available for gemcitabine and rucaparib

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity.
    Molecular oncology, 2013, Volume: 7, Issue:3

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemoradiotherapy; Deoxycytidine; Gemcitabine; Humans; Indoles; Pancreas; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors

2013
A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells.
    Cell cycle (Georgetown, Tex.), 2014, Volume: 13, Issue:24

    Topics: Antimetabolites, Antineoplastic; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Deoxycytidine; DNA Damage; Gemcitabine; Gene Library; Histones; Homologous Recombination; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Pancreatic Neoplasms; Rad51 Recombinase; Receptors, Calcitriol; RNA Interference; RNA, Small Interfering; Tumor Suppressor p53-Binding Protein 1

2014